サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1513928

臓器保存ソリューションの世界市場

Organ Preservation Solutions

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
臓器保存ソリューションの世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

臓器保存ソリューションの世界市場は2030年までに3億6,150万米ドルに達する見込み

2023年に2億5,740万米ドルと推定される臓器保存ソリューションの世界市場は、2023～2030年にかけてCAGR 5.0%で成長し、2030年には3億6,150万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである静的低温貯蔵技術は、CAGR 5.1％を記録し、分析期間終了時には1億6,180万米ドルに達すると予測されます。低体温マシン灌流技術セグメントの成長率は、分析期間中CAGR 6.0％と推定されます。

米国市場は6,840万米ドル、中国はCAGR4.7%で成長予測

米国の臓器保存ソリューション市場は、2023年に6,840万米ドルと推定されます。世界第2位の経済大国である中国は、2023～2030年にかけてCAGR 4.7%で成長し、2030年には5,710万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.5％と4.1％と予測されています。欧州では、ドイツがCAGR 3.8%で成長すると予測されています。

臓器保存ソリューション-主要動向と促進要因

臓器保存ソリューションは移植医療のセグメントで不可欠であり、臓器が採取されてからレシピエントに移植されるまでの間、臓器の生存性を維持するという重要な機能を果たしています。これらの溶液は、細胞の損傷を最小限に抑え、保存期間を延長するために特別に調合されており、臓器が移植のために機能的で生存可能であることを保証します。臓器保存ソリューションの開発と使用は大きく発展し、様々な臓器の保存ニーズや様々な保存期間に合わせて様々な化学組成が調整されています。ウィスコンシン大学（UW）溶液、ヒスチジン・トリプトファン・ケトグルタル酸（HTK）溶液、セルシオ溶液などが有名で、それぞれ低温虚血時間を短縮し、移植後の臓器機能を改善することにより、治療成績を最適化するように設計されています。臓器保存技術の進歩が続き、臓器不全の発生率の上昇により臓器移植の世界の需要が増加しているため、これらのソリューションの市場は拡大しています。

臓器保存ソリューション市場の重要な動向の一つは、これらのソリューションの有効性と性能の向上を目指した研究開発の進行です。研究者たちは、細胞代謝を維持するために保存中の臓器に継続的に酸素を供給する酸素灌流などの革新的な技術を模索しています。さらに、保存中の酸化ストレスや細胞障害を軽減するために、保存液に抗酸化剤やその他の保護剤を含めることも研究されています。もう一つの有望な進歩は、臓器を通して保存液を持続的に循環させることができる機械灌流技術の利用が増加していることです。この技術は、臓器の機能をより生理的な状態に近づけることによって、保存期間を延長し、移植成功率を向上させる大きな可能性を示しています。このような技術の進歩は、ドナー臓器の危機的な不足に対処し、移植プロセス全体の効率を向上させる上で不可欠です。臓器保存ソリューションを個々の臓器や患者の特定のニーズに合わせてカスタマイズする個別化医療アプローチの採用は、このセグメントの技術革新と改善をさらに促進すると予想されます。

臓器保存ソリューション市場の成長は、糖尿病、高血圧、心臓病などの慢性疾患の罹患率の上昇など、臓器不全とそれに続く移植の必要性につながるいくつかの要因によって牽引されています。高齢者は臓器移植を必要とする疾患に罹患する可能性が高いため、高齢化社会の進展も臓器移植需要の増加に寄与しています。さらに、手術手技の進歩や移植後のケアの改善により、臓器移植手術の件数は世界的に増加しています。低体温灌流や常温灌流などの保存法における技術的進歩は、臓器の生存能力を著しく高め、市場の需要を牽引しています。低体温灌流では臓器を冷却し、冷たい保存液で連続的に灌流します。一方、正常温熱灌流では臓器を通常の体温に維持し、酸素を含む血液または保存液を供給します。これらの方法は、移植後の臓器の生存率と機能において、改善された結果を示しています。さらに、新興国における医療インフラの拡大や、臓器提供と移植を支援する政府のイニシアチブの増加が、市場の成長に寄与しています。例えば、多くの国が臓器提供を奨励し、ドナー臓器の管理を改善するための政策やプログラムを実施しています。ドナーとレシピエントのマッチング改善や臓器輸送の効率化など、ドナー臓器管理の改善が移植の成功率をさらに高めています。さらに、より優れた有効性と保存期間の長さを備えた革新的な保存ソリューションの市場開拓が、今後数年間の市場成長を維持すると予想されます。これらの要因が複合的に作用することで、臓器保存ソリューション市場は、移植成績の向上と移植に利用可能な臓器の増加という特徴を持つ有望な将来に向けて推進されています。

調査対象企業の例（注目の13社）

  • 21st Century Medicine
  • BioLife Solutions, Inc.
  • Dr. Franz Kohler Chemie GmbH
  • Essential Pharmaceuticals, LLC
  • Lifeline Scientific, Inc.
  • Preservation Solutions, Inc.
  • XVIVO Perfusion AB

目次

第1章 調査手法

第2章 エグゼクティブ概要

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の展望

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他の欧州
  • アジア太平洋
  • その他

第4章 競合

目次
Product Code: MCP-6177

Global Organ Preservation Solutions Market to Reach US$361.5 Million by 2030

The global market for Organ Preservation Solutions estimated at US$257.4 Million in the year 2023, is expected to reach US$361.5 Million by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Static Cold Storage Technique, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$161.8 Million by the end of the analysis period. Growth in the Hypothermic Machine Perfusion Technique segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$68.4 Million While China is Forecast to Grow at 4.7% CAGR

The Organ Preservation Solutions market in the U.S. is estimated at US$68.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$57.1 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Organ Preservation Solutions - Key Trends and Drivers

Organ preservation solutions are indispensable in the field of transplant medicine, serving the critical function of maintaining the viability of organs from the time they are harvested until they are transplanted into the recipient. These solutions are specially formulated to minimize cellular damage and extend the preservation period, ensuring that organs remain functional and viable for transplantation. The development and use of organ preservation solutions have evolved significantly, with various chemical compositions being tailored to meet the preservation needs of different organs and varying preservation durations. Notable solutions include the University of Wisconsin (UW) solution, Histidine-Tryptophan-Ketoglutarate (HTK) solution, and Celsior solution, each designed to optimize outcomes by reducing cold ischemia time and improving post-transplant organ function. The market for these solutions is expanding as advancements in organ preservation technology continue to emerge, and the global demand for organ transplants increases due to a rising incidence of organ failure.

One of the significant trends in the organ preservation solutions market is the ongoing research and development aimed at enhancing the efficacy and performance of these solutions. Researchers are exploring innovative techniques such as oxygenated perfusion, which involves continuously supplying oxygen to the organs during preservation to maintain cellular metabolism. Additionally, the inclusion of antioxidants and other protective agents in preservation solutions is being investigated to reduce oxidative stress and cellular damage during storage. Another promising advancement is the increasing use of machine perfusion technologies, which allow for the continuous circulation of preservation solutions through the organ. This technique has shown significant potential in extending preservation times and improving transplant success rates by maintaining organ functionality closer to physiological conditions. These technological advancements are vital in addressing the critical shortage of donor organs and improving the overall efficiency of the transplantation process. The adoption of personalized medicine approaches, where preservation solutions are customized to meet the specific needs of individual organs and patients, is expected to further drive innovation and improvements in this field.

The growth in the organ preservation solutions market is driven by several factors, including the rising incidence of chronic diseases such as diabetes, hypertension, and heart disease, which lead to organ failure and the subsequent need for transplants. The growing aging population also contributes to the increased demand for organ transplants, as older individuals are more likely to suffer from conditions that necessitate organ replacement. Furthermore, the number of organ transplant procedures is increasing globally, driven by advancements in surgical techniques and improved post-transplant care. Technological advancements in preservation methods, such as hypothermic and normothermic perfusion, are significantly enhancing organ viability and driving market demand. Hypothermic perfusion involves cooling the organ and continuously perfusing it with a cold preservation solution, while normothermic perfusion maintains the organ at normal body temperature and provides oxygenated blood or preservation solution. These methods have shown improved outcomes in terms of organ viability and function post-transplant. Additionally, the expanding healthcare infrastructure in emerging economies and increased government initiatives to support organ donation and transplantation are contributing to market growth. For example, many countries are implementing policies and programs to encourage organ donation and improve the management of donor organs. Improvements in donor organ management practices, such as better matching of donors and recipients and more efficient logistics for organ transportation, are further enhancing the success rates of transplants. Moreover, the development of innovative preservation solutions with better efficacy and longer preservation times is expected to sustain market growth in the coming years. The combined effect of these factors is propelling the organ preservation solutions market toward a promising future, characterized by improved transplant outcomes and increased availability of viable organs for transplantation.

Select Competitors (Total 13 Featured) -

  • 21st Century Medicine
  • BioLife Solutions, Inc.
  • Dr. Franz Kohler Chemie GmbH
  • Essential Pharmaceuticals, LLC
  • Lifeline Scientific, Inc.
  • Preservation Solutions, Inc.
  • XVIVO Perfusion AB

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Organ Preservation Solutions - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Chronic Diseases Spurs Demand for Organ Preservation Solutions
    • Aging Population Expands Addressable Market Opportunity for Organ Transplantation
    • Advances in Preservation Technology Strengthen Business Case for Enhanced Solutions
    • Increasing Adoption of Machine Perfusion Techniques Propels Market Growth
    • Innovations in Oxygenated Perfusion Generate Demand for Improved Organ Viability
    • Growing Use of Antioxidants in Solutions Accelerates Demand for Advanced Preservation Methods
    • Government Initiatives to Support Organ Donation Drive Market Expansion
    • Surge in Organ Transplant Procedures Sustains Market Growth
    • Developments in Hypothermic Perfusion Methods Expand Market Potential
    • Growing Focus on Normothermic Perfusion Strengthens Market Opportunities
    • Improved Donor Organ Management Practices Generate Market Demand for Efficient Solutions
    • Enhanced Logistics for Organ Transportation Sustain Growth in the Preservation Solutions Market
    • Adoption of Single-Use Devices in Organ Preservation Propels Market Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Organ Preservation Solutions Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Organ Preservation Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Organ Preservation Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Organ Preservation Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Static Cold Storage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Static Cold Storage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Static Cold Storage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hypothermic Machine Perfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hypothermic Machine Perfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Hypothermic Machine Perfusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Normothermic Machine Perfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Normothermic Machine Perfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Normothermic Machine Perfusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Kidneys by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Kidneys by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Kidneys by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Lungs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Lungs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Lungs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Organ Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Organ Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Organ Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Organ Preservation Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Organ Preservation Solutions by Technique - Percentage Breakdown of Value Sales for Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Organ Preservation Solutions by Organ Type - Percentage Breakdown of Value Sales for Kidneys, Liver, Lungs, Heart and Other Organ Types for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Organ Preservation Solutions by Technique - Percentage Breakdown of Value Sales for Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Organ Preservation Solutions by Organ Type - Percentage Breakdown of Value Sales for Kidneys, Liver, Lungs, Heart and Other Organ Types for the Years 2014, 2024 & 2030
  • JAPAN
    • Organ Preservation Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Organ Preservation Solutions by Technique - Percentage Breakdown of Value Sales for Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Organ Preservation Solutions by Organ Type - Percentage Breakdown of Value Sales for Kidneys, Liver, Lungs, Heart and Other Organ Types for the Years 2014, 2024 & 2030
  • CHINA
    • Organ Preservation Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Organ Preservation Solutions by Technique - Percentage Breakdown of Value Sales for Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Organ Preservation Solutions by Organ Type - Percentage Breakdown of Value Sales for Kidneys, Liver, Lungs, Heart and Other Organ Types for the Years 2014, 2024 & 2030
  • EUROPE
    • Organ Preservation Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Organ Preservation Solutions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Organ Preservation Solutions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Organ Preservation Solutions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Organ Preservation Solutions by Technique - Percentage Breakdown of Value Sales for Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Organ Preservation Solutions by Organ Type - Percentage Breakdown of Value Sales for Kidneys, Liver, Lungs, Heart and Other Organ Types for the Years 2014, 2024 & 2030
  • FRANCE
    • Organ Preservation Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Organ Preservation Solutions by Technique - Percentage Breakdown of Value Sales for Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques for the Years 2014, 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Organ Preservation Solutions by Organ Type - Percentage Breakdown of Value Sales for Kidneys, Liver, Lungs, Heart and Other Organ Types for the Years 2014, 2024 & 2030
  • GERMANY
    • Organ Preservation Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Organ Preservation Solutions by Technique - Percentage Breakdown of Value Sales for Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques for the Years 2014, 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Organ Preservation Solutions by Organ Type - Percentage Breakdown of Value Sales for Kidneys, Liver, Lungs, Heart and Other Organ Types for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Organ Preservation Solutions by Technique - Percentage Breakdown of Value Sales for Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques for the Years 2014, 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Organ Preservation Solutions by Organ Type - Percentage Breakdown of Value Sales for Kidneys, Liver, Lungs, Heart and Other Organ Types for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Organ Preservation Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Organ Preservation Solutions by Technique - Percentage Breakdown of Value Sales for Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques for the Years 2014, 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Organ Preservation Solutions by Organ Type - Percentage Breakdown of Value Sales for Kidneys, Liver, Lungs, Heart and Other Organ Types for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Organ Preservation Solutions by Technique - Percentage Breakdown of Value Sales for Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Organ Preservation Solutions by Organ Type - Percentage Breakdown of Value Sales for Kidneys, Liver, Lungs, Heart and Other Organ Types for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Organ Preservation Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Organ Preservation Solutions by Technique - Percentage Breakdown of Value Sales for Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques for the Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Organ Preservation Solutions by Organ Type - Percentage Breakdown of Value Sales for Kidneys, Liver, Lungs, Heart and Other Organ Types for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Organ Preservation Solutions by Technique - Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for Organ Preservation Solutions by Technique - Percentage Breakdown of Value Sales for Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Techniques for the Years 2014, 2024 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Organ Preservation Solutions by Organ Type - Kidneys, Liver, Lungs, Heart and Other Organ Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of World 16-Year Perspective for Organ Preservation Solutions by Organ Type - Percentage Breakdown of Value Sales for Kidneys, Liver, Lungs, Heart and Other Organ Types for the Years 2014, 2024 & 2030

IV. COMPETITION